IP Verse

Methods Of Making Chimeric Antigen Receptor -Expressing Cells

Patent No. EP3397755 (titled "Methods Of Making Chimeric Antigen Receptor -Expressing Cells") was filed by Novartis on Dec 27, 2016. The application was issued on Nov 6, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
STRAWMANAug 1, 2025HASELTINE LAKE KEMPNER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3397755

NOVARTIS
Application Number
EP16829368A
Filing Date
Dec 27, 2016
Status
Granted And Under Opposition
Oct 3, 2024
Publication Date
Nov 6, 2024
External Links
Slate, Register , Google Patents